<p>Molecular Requirements for the Expression of Antiplatelet Effects by Synthetic Structural Optimized Analogues of the Anticancer Drugs Imatinib and Nilotinib</p>
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.